We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Altria (MO) Q1 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
In its upcoming report, Altria (MO - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.24 per share, reflecting an increase of 0.8% compared to the same period last year. Revenues are forecasted to be $4.56 billion, representing a year-over-year increase of 0.9%.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some Altria metrics that Wall Street analysts commonly model and monitor.
Analysts predict that the 'Revenues net of excise taxes- Oral Tobacco Products' will reach $630.74 million. The estimate indicates a year-over-year change of +0.3%.
The consensus among analysts is that 'Revenues net of excise taxes- Smokeable Products' will reach $3.90 billion. The estimate indicates a change of -0.2% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Operating Companies Income- Reported OCI- Oral Tobacco Products' of $430.43 million. Compared to the present estimate, the company reported $433.00 million in the same quarter last year.
Analysts' assessment points toward 'Operating Companies Income- Adjusted OCI- Smokeable Products' reaching $2.51 billion. The estimate is in contrast to the year-ago figure of $2.52 billion.
Over the past month, shares of Altria have returned +0.6% versus the Zacks S&P 500 composite's +9.3% change. Currently, MO carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Unveiling Altria (MO) Q1 Outlook: Wall Street Estimates for Key Metrics
In its upcoming report, Altria (MO - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.24 per share, reflecting an increase of 0.8% compared to the same period last year. Revenues are forecasted to be $4.56 billion, representing a year-over-year increase of 0.9%.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some Altria metrics that Wall Street analysts commonly model and monitor.
Analysts predict that the 'Revenues net of excise taxes- Oral Tobacco Products' will reach $630.74 million. The estimate indicates a year-over-year change of +0.3%.
The consensus among analysts is that 'Revenues net of excise taxes- Smokeable Products' will reach $3.90 billion. The estimate indicates a change of -0.2% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Operating Companies Income- Reported OCI- Oral Tobacco Products' of $430.43 million. Compared to the present estimate, the company reported $433.00 million in the same quarter last year.
Analysts' assessment points toward 'Operating Companies Income- Adjusted OCI- Smokeable Products' reaching $2.51 billion. The estimate is in contrast to the year-ago figure of $2.52 billion.
View all Key Company Metrics for Altria here>>>Over the past month, shares of Altria have returned +0.6% versus the Zacks S&P 500 composite's +9.3% change. Currently, MO carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .